Rhumbline Advisers Amneal Pharmaceuticals, Inc. Put Options Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMRX
# of Institutions
185Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$184 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$124 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$104 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$95.6 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$90.8 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.28B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...